MaxCyte
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell MaxCyte and other ETFs, options, and stocks.About MXCT
MaxCyte, Inc. engages in the development and licensing of cell-engineering technologies to pharmaceutical and biotechnology companies. Its propriety cell therapy is used in drug discovery and development, and biomanufacturing.
CEOMaher Masoud
CEOMaher Masoud
Employees114
Employees114
HeadquartersRockville, Maryland
HeadquartersRockville, Maryland
Founded1998
Founded1998
Employees114
Employees114
MXCT Key Statistics
Market cap137.61M
Market cap137.61M
Price-Earnings ratio-3.00
Price-Earnings ratio-3.00
Dividend yield—
Dividend yield—
Average volume623.25K
Average volume623.25K
High today$1.31
High today$1.31
Low today$1.28
Low today$1.28
Open price$1.29
Open price$1.29
Volume109.73K
Volume109.73K
52 Week high$5.20
52 Week high$5.20
52 Week low$1.25
52 Week low$1.25
Stock Snapshot
The current MaxCyte(MXCT) stock price is $1.29, with a market capitalization of 137.61M. The stock trades at a price-to-earnings (P/E) ratio of -3.00.
During the trading session on 2026-01-16, MaxCyte(MXCT) shares reached a daily high of $1.31 and a low of $1.28. At a current price of $1.29, the stock is +0.8% higher than the low and still -1.5% under the high.
Trading activity shows a volume of 109.73K, compared to an average daily volume of 623.25K.
The stock's 52-week range extends from a low of $1.25 to a high of $5.20.
The stock's 52-week range extends from a low of $1.25 to a high of $5.20.
Analyst ratings
71%
of 7 ratingsBuy
71.4%
Hold
28.6%
Sell
0%
People also own
Based on the portfolios of people who own MXCT. This list is generated using Robinhood data, and it’s not a recommendation.